Pediatric head and neck malignancies

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 17, Issue 6, 2009, Pages 471-476

  Chadha, Neil K ^a   Forte, Vito ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Child; Head and neck; Lymphoma; Malignancy; Rhabdomyosarcoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

CANCER EPIDEMIOLOGY; CHILDHOOD CANCER; GENETIC VARIABILITY; HEAD AND NECK CANCER; HODGKIN DISEASE; HUMAN; NASOPHARYNX CARCINOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SALIVARY GLAND CANCER; THYROID CANCER; THYROID MEDULLARY CARCINOMA; TREATMENT INDICATION;

CHILD; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOMA; RHABDOMYOSARCOMA; THYROID NEOPLASMS;

EID: 74949097176     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3283323893     Document Type: Review

References (41)

1. Albright JT, Topham AK, Reilly JS. Pediatric head and neck malignancies: US incidence and trends over 2 decades. Arch Otolaryngol Head Neck Surg 2002; 128:655-659.
2. Cofer BR, Wiener ES. Rhabdomyosarcoma. In: Andrassy RJ, editor. Pediatric surgical oncology. Philadelphia: W.B. Saunders; 1998. pp. 221- 237.
3. Simon JH, Paulino AC, Smith RB, et al. Prognostic factors in head and neck rhabdomyosarcoma. Head Neck 2002; 24:468-473.
4. Miller RW, Young JL Jr, Novakovic B. Childhood cancer. Cancer 1995; 75:395-405.
5. Toro JR, Travis LB, Wu HJ, et al. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26 758 cases. Int J Cancer 2006; 119:2922-2930.
6. Leaphart C, Rodeberg D. Pediatric surgical oncology: management of rhabdomyosarcoma. Surg Oncol 2007; 16:173-185.
7. Oda Y, Tsuneyoshi M. Recent advances in the molecular pathology of soft tissue sarcoma: implications for diagnosis, patient prognosis, and molecular target therapy in the future. Cancer Sci 2008; 100:200-208.
8. Sorensen PH, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol 2002; 20:2672-2679.
9. Walterhouse DO, Pappo AS, Baker KS, et al. Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study Group. Cancer 2001; 92:3135-3146.
10. Gillespie MB, Marshall DT, Day TA, et al. Pediatric rhabdomyosarcoma of the head and neck. Curr Treat Options Oncol 2006; 7:13-22.
11. Pappo AS, Meza JL, Donaldson SS, et al. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV. J Clin Oncol 2003; 21:638-645.
12. Daya H, Chan HS, Sirkin W, et al. Pediatric rhabdomyosarcoma of the head and neck: is there a place for surgical management? Arch Otolaryngol Head Neck Surg 2000; 126:468-472.
13. Horner MJ, Ries LAG, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975-2006. Bethesda, Maryland: National Cancer Institute; 2009.
14. Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006; 107:1711-1742.
15. Williams ED, Abrosimov A, Bogdanova T, et al. Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br J Cancer 2004; 90:2219-2224.
16. Maule M, Scelo G, Pastore G, et al. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. J Natl Cancer Inst 2007; 99:790-800.
17. Williams ED, Abrosimov A, Bogdanova T, et al. Morphologic characteristics of Chernobyl-related childhood papillary thyroid carcinomas are independent of radiation exposure but vary with iodine intake. Thyroid 2008; 18:847-852.
18. Dinauer CA, Breuer C, Rivkees SA. Differentiated thyroid cancer in children: diagnosis and management. Curr Opin Oncol 2008; 20:59-65.
19. Sanso GE, Domene HM, Garcia R, et al. Very early detection of RET protooncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Cancer 2002; 94:323-330.
20. Machens A, Ukkat J, Brauckhoff M, et al. Advances in the management of hereditary medullary thyroid cancer. J Intern Med 2005; 257:50-59.
21. Moore SW, Appfelstaedt J, Zaahl MG. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2. J Pediatr Surg 2007; 42:326-332.
22. Bradley P, McClelland L, Mehta D. Paediatric salivary gland epithelial neoplasms. ORL J Otorhinolaryngol Relat Spec 2007; 69:137-145.
23. Guzzo M, Ferrari A, Marcon I, et al. Salivary gland neoplasms in children: the experience of the Istituto Nazionale Tumori of Milan. Pediatr Blood Cancer 2006; 47:806-810.
24. Kessler A, Handler SD. Salivary gland neoplasms in children: a 10-year survey at the Children's Hospital of Philadelphia. Int J Pediatr Otorhinolaryngol 1994; 29:195-202.
25. Haddad M, Triglia JM, Helardot P, et al. Localized cervical neuroblastoma: prevention of surgical complications. Int J Pediatr Otorhinolaryngol 2003; 67:1361-1367.
26. Mehta K, Haller JO, Legasto AC. Imaging neuroblastoma in children. Crit Rev Comput Tomogr 2003; 44:47-61.
27. de Kraker J, Hoefnagel KA, Verschuur AC, et al. Iodine-131- metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age. Eur J Cancer 2008; 44:551-556.
28. Ayan I, Kaytan E, Ayan N. Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol 2003; 4:13-21.
29. Ayan I, Altun M. Nasopharyngeal carcinoma in children: retrospective review of 50 patients. Int J Radiat Oncol Biol Phys 1996; 35:485-492.
30. Orbach D, Brisse H, Helfre S, et al. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: radiotherapy dose adaptation after chemotherapy response to minimize late effects. Pediatr Blood Cancer 2008; 50:849-853.
31. O'Leary M, Sheaffer B, Keller F, et al. Lymphomas and reticuloendothelial neoplasms. In: Bleyer A, O'Leary M, Barr R, Ries LAG, editors. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. Bethesda, Maryland: National Cancer Institute; 2006. pp. 25-38.
32. Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med 1996; 334:1238-1248.
33. Gross TG, Termuhlen AM. Pediatric non-Hodgkin's lymphoma. Curr Oncol Rep 2007; 9:459-465.
34. Harley EH. Asymmetric tonsil size in children. Arch Otolaryngol Head Neck Surg 2002; 128:767-769.
35. de Kerviler E, de Bazelaire C, Mounier N, et al. Image-guided core-needle biopsy of peripheral lymph nodes allows the diagnosis of lymphomas. Eur Radiol 2007; 17:843-849.
36. Pfeiffer J, Kayser G, Ridder GJ. Sonography-assisted cutting needle biopsy in the head and neck for the diagnosis of lymphoma: can it replace lymph node extirpation? Laryngoscope 2009; 119:689-695.
37. Morris-Stiff G, Cheang P, Key S, et al. Does the surgeon still have a role to play in the diagnosis and management of lymphomas? World J Surg Oncol 2008; 6:13.
38. Burkhardt B, Woessmann W, Zimmermann M, et al. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J Clin Oncol 2006; 24:491-499.
39. Weiner MA, Leventhal BG, Marcus R, et al. Intensive chemotherapy and lowdose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol 1991; 9:1591-1598.
40. Olson MR, Donaldson SS. Treatment of pediatric Hodgkin lymphoma. Curr Treat Options Oncol 2008; 9:81-94.
41. Smith RS, Chen Q, Hudson MM, et al. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol 2003; 21:2026-2033.